CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 109 enrolled
Drug / intervention
Lotrafilcon B contact lenses +5 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01699750
NCT01699750N/ACompleted
CompareCT.gov

Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems

Alcon Research·interventional·Posted Oct 4, 2012·Updated Dec 8, 2014

In Brief

A clinical study evaluating Lotrafilcon B contact lenses, Senofilcon A contact lenses, and 4 other interventions for Myopia and 2 related conditions. Completed, enrolled 109 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the lipid uptake, wetting characteristics, and visual performance of AIR OPTIX® AQUA and ACUVUE® OASYS® with HYDRACLEAR® contact lenses when used in conjunction with two contact lens care systems.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Astigmatism, Refractive Error
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 4, 2012
Enrollment StartDec 1, 2012
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.7 years ago

Interventions

Lotrafilcon B contact lensesdevice

Silicone hydrogel contact lenses, Phase 2

Senofilcon A contact lensesdevice

Silicone hydrogel contact lenses, Phase 2

OPTI-FREE® PUREMOIST® MPDSdevice

Contact lens care system, Phase 2

BIOTRUE®device

Contact lens care system, Phase 2

Balafilcon A contact lensesdevice

Silicone hydrogel contact lenses worn for 30 days, Phase 1

ReNu® Multiplus®device

Contact lens care system used for 30 days, Phase 1